Randomized clinical trial of angiotensin-converting enzyme inhibitor, ramipril, in patients with intermittent claudication.


BACKGROUND The aim was to investigate the effect of ramipril on clinical parameters in patients with peripheral arterial disease. METHODS Patients with intermittent claudication were randomized to receive ramipril or placebo for 24 weeks in a double-blind study. Outcome measures were walking distance, arterial stiffness measurement and quality of life… (More)
DOI: 10.1002/bjs.9198


  • Presentations referencing similar topics